Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc.verified

VIRX

Price:

$0.00978

Market Cap:

$388.70K

Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's development pipeline includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and...[Read more]

Industry

Biotechnology

IPO Date

2005-09-27

Stock Exchange

OTC

Ticker

VIRX

The Enterprise Value as of December 2025 (TTM) for Viracta Therapeutics, Inc. (VIRX) is 4.17M

According to Viracta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.17M. This represents a change of -86.50% compared to the average of 30.92M of the last 4 quarters.

Viracta Therapeutics, Inc. (VIRX) Historical Enterprise Value (quarterly & annually)

How has VIRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Viracta Therapeutics, Inc. over the last ten years is 131.14M. The current 4.17M Enterprise Value has changed 218.20% with respect to the historical average. Over the past ten years (40 quarters), VIRX's Enterprise Value was at its highest in in the March 2020 quarter at 518.53M. The Enterprise Value was at its lowest in in the September 2024 quarter at 12.94M.

Quarterly (TTM)
Annual

Average

131.14M

Median

105.57M

Minimum

8.69M

Maximum

275.11M

Viracta Therapeutics, Inc. (VIRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Viracta Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.07%

Maximum Annual Enterprise Value = 275.11M

Minimum Annual Increase = -91.63%

Minimum Annual Enterprise Value = 8.69M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202335.25M-19.06%
202243.56M138.67%
202118.25M-91.63%
2020218.10M-20.72%
2019275.11M3.07%
20188.69M-87.75%
201770.92M-72.98%
2016262.41M9.86%
2015238.85M70.35%
2014140.22M-44.04%

Viracta Therapeutics, Inc. (VIRX) Average Enterprise Value

How has VIRX Enterprise Value performed in the past?

The current Enterprise Value of Viracta Therapeutics, Inc. (VIRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

32.35M

5-year avg

118.05M

10-year avg

131.14M

Viracta Therapeutics, Inc. (VIRX) Enterprise Value vs. Peers

How is VIRX’s Enterprise Value compared to its peers?

Viracta Therapeutics, Inc.’s Enterprise Value is greater than RespireRx Pharmaceuticals Inc. (3.37M), greater than THC Farmaceuticals, Inc. (399.07K), greater than DH Enchantment Inc. (2.99M), greater than Innovation Pharmaceuticals Inc. (-430157.00), greater than Regen BioPharma, Inc. (1.32M), greater than CuraScientific Corp (3.01M), greater than Actavia Life Sciences, Inc. (3.22M), greater than Levitee Labs Inc. (927.50K), greater than Wesana Health Holdings Inc. (450.46K), greater than Paradigm Medical Industries, Inc. (2.49M),

Build a custom stock screener for Viracta Therapeutics, Inc. (VIRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viracta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viracta Therapeutics, Inc. (VIRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viracta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Viracta Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Viracta Therapeutics, Inc. (VIRX)?

What is the 3-year average Enterprise Value for Viracta Therapeutics, Inc. (VIRX)?

What is the 5-year average Enterprise Value for Viracta Therapeutics, Inc. (VIRX)?

How does the current Enterprise Value for Viracta Therapeutics, Inc. (VIRX) compare to its historical average?